AstraZeneca Covid vaccine, thrombosis in rare cases: admission in court

The AstraZeneca vaccine was administered against Covid in more than 150 countries in the world. The pharmaceutical giant found itself playing a key role in the fight against the pandemic but, at the same time, at the center of debates and court proceedings.

For the first time he admitted a connection between the vaccine proposed on the market and some rare side effects. A potential turning point for the giant, which could find itself facing a large number of lawsuits seeking compensation. However, let's see in detail what was admitted and how.

Risk of thrombosis

Talking about Covid means touching a raw nerve for many. Although the echo of the pandemic in everyday life is quite distant today, the memory of the forced confinement, the tensions, the fear, the hospitalizations and the deaths will not go away from our minds so easily.

This is why it is so easy to ride the wave and talk about AstraZeneca finally admitting its faults, almost denouncing itself, according to many headlines. It is good to understand exactly what happened in court in the UKin order to have clearer ideas regarding possible implications.

The AstraZeneca vaccine was developed by the British-Swedish company, which collaborated with the University of Oxford. What was obtained was a product which, according to the studies conducted during the pandemic, resulted 60 to 80% effective in protecting against coronavirus.

In a phase of terror and alarm, it was necessary to respond quickly to the health emergency, consequently it was decided to continue at the same pace both with the distribution of the vaccine and with research into its possible side effects.

It was discovered that the vaccine could cause the disease in some subjects formation of blood clots, potentially fatal. This resulted in a class action lawsuit in the UKwhich demands compensation of up to 100 million pounds, or 117 million euros, for around 50 victims.

AstraZeneca's admission

AstraZeneca disputes the accusations made against its actions. At the same time, however, for the first time in one of the documents presented in court made an admission. His vaccine”in very rare cases it can cause TTS”. This acronym refers to the thrombosis syndrome with thrombocytopenia. This is characterized by blood clots and a low number of platelets.

The news was reported by TheTelegraph and the documents in question they date back to February 2024. The pharmaceutical company also reiterates how the causal mechanism is not yet known. This is an important point, as demonstrated by this quote: “TTS can occur even in the absence of the AZ vaccine (or any other vaccine). The causal link in each individual case will be subject to proof by experts.”

An opening sufficient to kick off numerous legal actions, strengthening those already started. The main impact, however, is to suddenly collapse that feeling of being fighting against windmills. A correlation exists and it's time to get one clear and official response on the cause report.

The foundations are being laid today for a future health and legislative balance. Many experts reiterate that overcoming Covid does not represent the end of the risk of pandemics, on the contrary. It cannot be ruled out that in the future we will find ourselves agreeing more with the WHO statistical vision: “In countries where transmission of SARS-CoV-2 is ongoing, the benefit of vaccination to protect against Covid-19 far outweighs the risks.”